Literature DB >> 24231205

Editorial comment.

Sarah D Blaschko1, Benjamin N Breyer1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24231205      PMCID： PMC4123195          DOI： 10.1016/j.urology.2013.08.062

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  6 in total

1.  Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score.

Authors:  So Ushijima; Osamu Ukimura; Koji Okihara; Yoichi Mizutani; Akihiro Kawauchi; Tsuneharu Miki
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

2.  An assessment of the comprehension of the American Urological Association Symptom Index.

Authors:  S A MacDiarmid; T C Goodson; T M Holmes; P R Martin; R B Doyle
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

3.  Prospective comparison of a new visual prostate symptom score versus the international prostate symptom score in men with lower urinary tract symptoms.

Authors:  Chris L E van der Walt; Chris F Heyns; Adam E Groeneveld; Rachel S Edlin; Stephan P J van Vuuren
Journal:  Urology       Date:  2011-05-07       Impact factor: 2.649

4.  Correlation between a new visual prostate symptom score (VPSS) and uroflowmetry parameters in men with lower urinary tract symptoms.

Authors:  C F Heyns; C L E van der Walt; A E Groeneveld
Journal:  S Afr Med J       Date:  2012-03-07

5.  Patient misunderstanding of the individual questions of the American Urological Association symptom score.

Authors:  Timothy V Johnson; Ammara Abbasi; Samantha S Ehrlich; Renee S Kleris; Evan D Schoenberg; Ashli Owen-Smith; Michael Goodman; Viraj A Master
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

6.  The influence of patient education level on the International Prostatic Symptom Score.

Authors:  N R Netto Júnior; M L de Lima
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.